Haemophilus influenzae Type b/Polyribosylribitol Phosphate-Tetanus (Hib/PRP-T) Vaccine Safety, Phase I Study. International Journal of Integrated Health Sciences, v. 3, n. 2, p. 55–59, 17 Sep.2015.